中文

EVENTS

Cooperation and Development—Huaige Capital CEO Forum and Meeting of Fund Investors

Cooperation and Development—Huaige Capital CEO Forum and Meeting of Fund Investors

On November 30, 2019, Huaige Capital held a CEO Forum and Meeting of Fund Investors in Shanghai under the theme of Cooperation and Development. More
HG Porfolio|Huaige Portfolio Company KDL Medical(1501.HK) Successfully Listed on the Main Board of H

HG Porfolio|Huaige Portfolio Company KDL Medical(1501.HK) Successfully Listed on the Main Board of H

November 8th, 2019, Shanghai Kindly Medical Instruments Co., Ltd. (“KDL Medical” or “company”) was successfully listed on Hong Kong Stock Exchange main board (stock code: 1501, stock abbreviation: KDL MEDICAL). KDL Medical issued 40 million new shares in the global offering and was priced at HK$20.80 per share, More
HG Porfolio|Resproly Announced Close of Series A Financing of 50 million RMB Led by Huaige Capital,

HG Porfolio|Resproly Announced Close of Series A Financing of 50 million RMB Led by Huaige Capital,

​August 27th, 2019, Zhuhai, the ceremony celebrating the signing of Zhuhai Resproly Biopharmaceutical Co., Ltd (“Resproly”, or “company”) Series A financing agreement as well as the opening of Resproly’s new headquarter was held at Jinwan Healthcare Hub, Zhuhai. More
HG Porfolio|Nanjing Leads Biolabs Announced NMPA Approval for Clinical Trial of LBL-007, a Novel Ful

HG Porfolio|Nanjing Leads Biolabs Announced NMPA Approval for Clinical Trial of LBL-007, a Novel Ful

Nanjing Leads Biolabs Co., Ltd (“Leads Biolabs” or “company”), announced that its proprietary fully human anti-LAG-3 monoclonal antibody, LBL-007, has been recently granted permission to clinical trial by NMPA following submitting the clinical trial application in May, 2019. More
HG Porfolio|Signing Ceremony for the Capital Increase and Share Transfer Agreement of Guangxi Ouwen

HG Porfolio|Signing Ceremony for the Capital Increase and Share Transfer Agreement of Guangxi Ouwen

On August 26, 2018 at 10:00 a.m., the signing ceremony for the Capital Increase and Share Transfer Agreement between Zhuhai Kindly Medical Devices Co., Ltd. (“Zhuhai Kindly”), a wholly-owned subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd. (“Kindly”), and Guangxi Ouwen Medical Technology Group Co., Ltd. More

huaigecapital
Copyright © 2019 宁波怀格健康投资管理合伙企业（有限合伙）. 浙ICP备20007001号-1